Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Norwalk VLP Vaccine Challenge Study
NCT00973284Phase 2Completed
- Sponsor
- Takeda
- Start
- Aug 2009
- Primary completion
- Apr 2010
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Norwalk VLP vaccine in Norovirus Infection, sponsored by Takeda. Started Aug 2009; status: completed.
02
Drugs
Norwalk VLP vaccine
03
Conditions
Norovirus Infection
Beyond the preview
Go deeper on NCT00973284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973284.